Nantahala Capital Management, LLC - 06 Nov 2024 Form 3 Insider Report for Evoke Pharma Inc (EVOK)

Role: 10%+ Owner
Signature: /s/ Taki Vasilakis, Chief Compliance Officer, Nantahala Capital Management, LLC
Issuer symbol: EVOK
Transactions as of: 06 Nov 2024
Net transactions value: $0
Form type: 3
Filing time: 15 Nov 2024, 16:31:10 UTC
Previous filing: 18 Jun 2024
Next filing: 30 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	EVOK	Common Stock						148,194	06 Nov 2024	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	EVOK	Pre-Funded Warrants	06 Nov 2024	Common Stock	433,962	$0.000100	See footnote	F1
holding	EVOK	Series A Common Stock Purchase Warrants	06 Nov 2024	Common Stock	117,019	$8.16	See footnote	F1
holding	EVOK	Series B Common Stock Purchase Warrants	06 Nov 2024	Common Stock	245,080	$8.16	See footnote	F1
holding	EVOK	Series C Common Stock Purchase Warrants	06 Nov 2024	Common Stock	117,019	$8.16	See footnote	F1
holding	EVOK	Amended Series A Common Stock Purchase Warrants	06 Nov 2024	Common Stock	158,682	$0.0100	See footnote	F1
holding	EVOK	Amended Series C Common Stock Purchase Warrants	06 Nov 2024	Common Stock	250,627	$0.0100	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Nantahala Capital Management, LLC ("NCM"), an investment adviser to certain private funds and managed accounts (the "NCM Investors") that hold the Evoke Pharma, Inc. ("Issuer") securities disclosed in this statement, may be deemed a beneficial owner of such securities. Each of Mr. Wilmot B. Harkey and Mr. Daniel Mack may be deemed a beneficial owner of Issuer securities beneficially owned by NCM. Each of NCM, Mr. Harkey and Mr. Mack disclaims beneficial ownership of the Issuer's securities disclosed herein except to the extent of their respective pecuniary interests therein.

Content

Nantahala Capital Management, LLC ("NCM"), an investment adviser to certain private funds and managed accounts (the "NCM Investors") that hold the Evoke Pharma, Inc. ("Issuer") securities disclosed in this statement, may be deemed a beneficial owner of such securities. Each of Mr. Wilmot B. Harkey and Mr. Daniel Mack may be deemed a beneficial owner of Issuer securities beneficially owned by NCM. Each of NCM, Mr. Harkey and Mr. Mack disclaims beneficial ownership of the Issuer's securities disclosed herein except to the extent of their respective pecuniary interests therein.